Brupharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Brupharma
Largest movements
- Cash +€164,024
up €164,024 (+833.4%), from €19,681 to €183,705
mainly Current investments (+€150,000) and Depreciation (+€59,444)
- Current investments -€150,000
no longer reported in 2025 (was €150,000)
- Tangible fixed assets -€51,089
down €51,089 (-23.4%), from €218,113 to €167,024
of which Furniture and vehicles: -€27,952
- Reserves -€50,743
down €50,743 (-24.6%), from €206,632 to €155,889
of which Distributable reserves: -€50,743
- Other debts +€17,028
up €17,028 (+47.1%), from €36,136 to €53,163
- Gross operating margin -€38,833
down €38,833 (-33.9%), from €114,672 to €75,839
- Depreciation -€32,141
down €32,141 (-35.1%), from €91,585 to €59,444
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €395,058 | €360,003 | -€35,054 | -8.9% |
| Fixed assets | 21/28 | €218,155 | €167,066 | -€51,089 | -23.4% |
| Tangible fixed assets | 22/27 | €218,113 | €167,024 | -€51,089 | -23.4% |
| Land and buildings | 22 | €130,251 | €121,450 | -€8,801 | -6.8% |
| Plant, machinery and equipment | 23 | €34,292 | €19,956 | -€14,336 | -41.8% |
| Furniture and vehicles | 24 | €53,570 | €25,618 | -€27,952 | -52.2% |
| Financial fixed assets | 28 | €42 | €42 | = | 0.0% |
| Current assets | 29/58 | €176,902 | €192,937 | +€16,035 | +9.1% |
| Amounts receivable within one year | 40/41 | €2,129 | €4,698 | +€2,569 | +120.7% |
| Trade receivables | 40 | - | €4 | +€4 | |
| Other amounts receivable | 41 | €2,129 | €4,694 | +€2,565 | +120.5% |
| Current investments | 50/53 | €150,000 | - | -€150,000 | |
| Cash at bank and in hand | 54/58 | €19,681 | €183,705 | +€164,024 | +833.4% |
| Deferred charges and accrued income | 490/1 | €5,092 | €4,534 | -€558 | -11.0% |
| Total equity and liabilities | 10/49 | €395,058 | €360,003 | -€35,054 | -8.9% |
| Equity | 10/15 | €225,232 | €174,489 | -€50,743 | -22.5% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €206,632 | €155,889 | -€50,743 | -24.6% |
| Tax-exempt reserves | 132 | €1,116 | €1,116 | = | 0.0% |
| Distributable reserves | 133 | €205,517 | €154,774 | -€50,743 | -24.7% |
| Amounts payable | 17/49 | €169,826 | €185,514 | +€15,689 | +9.2% |
| Amounts payable after more than one year | 17 | €117,400 | €117,400 | = | 0.0% |
| Other amounts payable | 178/9 | €117,400 | €117,400 | = | 0.0% |
| Amounts payable within one year | 42/48 | €42,956 | €59,788 | +€16,832 | +39.2% |
| Trade debts | 44 | €4,634 | €3,745 | -€890 | -19.2% |
| Suppliers | 440/4 | €4,634 | €3,745 | -€890 | -19.2% |
| Advances received on contracts in progress | 46 | €9 | €9 | = | 0.0% |
| Taxes, remuneration and social security | 45 | €2,177 | €2,871 | +€694 | +31.9% |
| Taxes | 450/3 | €1,904 | €2,591 | +€687 | +36.1% |
| Remuneration and social security | 454/9 | €272 | €280 | +€7 | +2.7% |
| Other amounts payable | 47/48 | €36,136 | €53,163 | +€17,028 | +47.1% |
| Accrued charges and deferred income | 492/3 | €9,470 | €8,326 | -€1,144 | -12.1% |
| Remuneration, social security and pensions | 62 | €4,149 | €4,310 | +€161 | +3.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €91,585 | €59,444 | -€32,141 | -35.1% |
| Other operating charges | 640/8 | €4,630 | €4,142 | -€488 | -10.5% |
| Gross operating margin | 9900 | €114,672 | €75,839 | -€38,833 | -33.9% |
| Operating profit (loss) | 9901 | €14,308 | €7,942 | -€6,366 | -44.5% |
| Financial income | 75/76B | €780 | €895 | +€115 | +14.7% |
| Recurring financial income | 75 | €780 | €895 | +€115 | +14.7% |
| Financial charges | 65/66B | €9,474 | €8,376 | -€1,098 | -11.6% |
| Recurring financial charges | 65 | €9,474 | €8,376 | -€1,098 | -11.6% |
| Profit (loss) for the period before taxes | 9903 | €5,613 | €460 | -€5,152 | -91.8% |
| Income taxes | 67/77 | €1,900 | €1,203 | -€697 | -36.7% |
| Profit (loss) for the period | 9904 | €3,712 | -€743 | -€4,455 | |
| Profit (loss) for the period to be appropriated | 9905 | €3,712 | -€743 | -€4,455 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.